BMI, Metabolic Syndrome, And Pancreatic Cancer - Hallo friendsLET'S HEALTHY LIFE, In the article you read this time with the title BMI, Metabolic Syndrome, And Pancreatic Cancer, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cough, Article diabetes, Article diseases, Article in general, Article Phytotherapy, Article skin diseases, We write this you can understand. Alright, good read.

Title : BMI, Metabolic Syndrome, And Pancreatic Cancer
link : BMI, Metabolic Syndrome, And Pancreatic Cancer

BMI, Metabolic Syndrome, And Pancreatic Cancer

Here is study linking higher BMI, and higher fasting insulin levels (metabolic syndrome, insulin resistance), with an increased risk for pancreatic cancer.  The burden of morbidity and mortality caused by overweight/obesity is staggering, something to keep in mind when reading all the popular stories on the Internet that attempt to normalize obesity and rant about “fat shaming” and “body shaming.”  Being overweight is literally killing people, why normalize it?  Abstract:

BACKGROUND:

Risk factors for pancreatic cancer include a cluster of metabolic conditions such as obesity, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes. Given that these risk factors are correlated, separating out causal from confounded effects is challenging. Mendelian randomization (MR), or the use of genetic instrumental variables, may facilitate the identification of the metabolic drivers of pancreatic cancer.

METHODS:

We identified genetic instruments for obesity, body shape, dyslipidemia, insulin resistance, and type 2 diabetes in order to evaluate their causal role in pancreatic cancer etiology. These instruments were analyzed in relation to risk using a likelihood-based MR approach within a series of 7110 pancreatic cancer patients and 7264 control subjects using genome-wide data from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Potential unknown pleiotropic effects were assessed using a weighted median approach and MR-Egger sensitivity analyses.

RESULTS:

Results indicated a robust causal association of increasing body mass index (BMI) with pancreatic cancer risk (odds ratio [OR] = 1.34, 95% confidence interval [CI] = 1.09 to 1.65, for each standard deviation increase in BMI [4.6 kg/m2]). There was also evidence that genetically increased fasting insulin levels were causally associated with an increased risk of pancreatic cancer (OR = 1.66, 95% CI = 1.05 to 2.63, per SD [44.4 pmol/L]). Notably, no evidence of a causal relationship was observed for type 2 diabetes, nor for dyslipidemia. Sensitivity analyses did not indicate that pleiotropy was an important source of bias.

CONCLUSIONS:

Our results suggest a causal role of BMI and fasting insulin in pancreatic cancer etiology.

Thus Article BMI, Metabolic Syndrome, And Pancreatic Cancer

That's an article BMI, Metabolic Syndrome, And Pancreatic Cancer This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article BMI, Metabolic Syndrome, And Pancreatic Cancer with the link address https://letslifes.blogspot.com/2018/01/bmi-metabolic-syndrome-and-pancreatic.html

Tweet

Subscribe to receive free email updates: